Breast cancer mortality reflected differently in certain Georgia neighborhoods, study reveals

by Adam Pope,University of Alabama at BirminghamAssociations Between Area Depriviation Index (ADI) and Probability of Patient Mortality for Black and White Patients With Breast Cancer. Data are

Updated on: January 30,2024

Breast cancer mortality reflected differently in certain Georgia neighborhoods, study reveals

by Adam Pope,University of Alabama at BirminghamAssociations Between Area Depriviation Index (ADI) and Probability of Patient Mortality for Black and White Patients With Breast Cancer. Data are

Updated on:January 30,2024

New research identifies a potential treatment target for hepatoblastoma, the most common liver cancer in children

byElsevierLeft: Gross images of livers from mice transfected with β-catenin and YAP1(β-Y), β-catenin and YAP1 plus dominant negative HSF1 (dnHSF1-β-Y) and normal (control). Right: Liver to body

Updated on: January 13,2024

New research identifies a potential treatment target for hepatoblastoma, the most common liver cancer in children

byElsevierLeft: Gross images of livers from mice transfected with β-catenin and YAP1(β-Y), β-catenin and YAP1 plus dominant negative HSF1 (dnHSF1-β-Y) and normal (control). Right: Liver to body

Updated on:January 13,2024

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ

Updated on: February 20,2024

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ

Updated on:February 20,2024

New bladder cancer classification predicts treatment response

byCedars-Sinai Medical CenterStudy design and gene signatures of patients with high-risk NMIBC according to BCG response subtypes (BRS). Credit:Science Translational Medicine(2023).

Updated on: January 11,2024

New bladder cancer classification predicts treatment response

byCedars-Sinai Medical CenterStudy design and gene signatures of patients with high-risk NMIBC according to BCG response subtypes (BRS). Credit:Science Translational Medicine(2023).

Updated on:January 11,2024

Possible new cancer treatment target discovered

byUniversity of GothenburgChandrasekhar Kanduri and Meena Kanduri, Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg. Credit: Elin LindströmResearchers at the Univers

Updated on: December 28,2023

Possible new cancer treatment target discovered

byUniversity of GothenburgChandrasekhar Kanduri and Meena Kanduri, Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg. Credit: Elin LindströmResearchers at the Univers

Updated on:December 28,2023

Experimental AI method boosts doctors' ability to diagnose cancers and precancers of the esophagus

by Delthia Ricks , Medical XpressEndoscopic photographs of lesions in three false-negative patients. Credit:Science Translational Medicine(2024). DOI: 10.1126/scitranslmed.adk5395Artificia

Updated on: August 27,2024

Experimental AI method boosts doctors' ability to diagnose cancers and precancers of the esophagus

by Delthia Ricks , Medical XpressEndoscopic photographs of lesions in three false-negative patients. Credit:Science Translational Medicine(2024). DOI: 10.1126/scitranslmed.adk5395Artificia

Updated on:August 27,2024

Research tests cost-effective approach to early-cancer detection from cell-free DNA in blood samples

byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainEarly detection remains key to successfully treating many cancers, and early detection via cell-free DNA (cfDNA) circulati

Updated on: January 22,2024

Research tests cost-effective approach to early-cancer detection from cell-free DNA in blood samples

byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainEarly detection remains key to successfully treating many cancers, and early detection via cell-free DNA (cfDNA) circulati

Updated on:January 22,2024

Study reveals dual role of protein in cancer treatment

by Denise Heady,University of California, Los AngelesGraphical abstract. Credit:Cell Reports(2024). DOI: 10.1016/j.celrep.2024.114289Investigators at the UCLA Health Jonsson Comprehe

Updated on: July 17,2024

Study reveals dual role of protein in cancer treatment

by Denise Heady,University of California, Los AngelesGraphical abstract. Credit:Cell Reports(2024). DOI: 10.1016/j.celrep.2024.114289Investigators at the UCLA Health Jonsson Comprehe

Updated on:July 17,2024

Study offers new understanding of why kidney cancers become metastatic

by University of Texas M. D. Anderson Cancer CenterThis image shows a cross section of a kidney. Credit: Holly Fischer/WikipediaResearchers at The University of Texas MD Anderson Cancer have engi

Updated on: February 24,2024

Study offers new understanding of why kidney cancers become metastatic

by University of Texas M. D. Anderson Cancer CenterThis image shows a cross section of a kidney. Credit: Holly Fischer/WikipediaResearchers at The University of Texas MD Anderson Cancer have engi

Updated on:February 24,2024

Researcher pioneers method of detecting early-stage cancer: Cheaper, faster, less invasive and accurate

by Dave Raney,University of CincinnatiJiajie Diao and his collaboratorare working with UC’s Technology Transfer team to commercialize their new method for early cancer diagnosis. Credit: C

Updated on: January 30,2024

Researcher pioneers method of detecting early-stage cancer: Cheaper, faster, less invasive and accurate

by Dave Raney,University of CincinnatiJiajie Diao and his collaboratorare working with UC’s Technology Transfer team to commercialize their new method for early cancer diagnosis. Credit: C

Updated on:January 30,2024

Combination treatment shows promise in patients with chemotherapy-resistant urothelial cancer

byWolters Kluwer HealthGraphical abstract. Credit:Journal of Urology(2022). DOI: 10.1097/JU.0000000000002969A combination of two types of cancer-fighting treatments—the immunotherapy

Updated on: December 28,2023

Combination treatment shows promise in patients with chemotherapy-resistant urothelial cancer

byWolters Kluwer HealthGraphical abstract. Credit:Journal of Urology(2022). DOI: 10.1097/JU.0000000000002969A combination of two types of cancer-fighting treatments—the immunotherapy

Updated on:December 28,2023

Rucaparib efficacious in metastatic castration-resistant prostate cancer

by Elana GotkineFor patients with metastatic castration-resistant prostate cancer, treatment with rucaparib is associated with significantly longer duration of imaging-based progression-free survival

Updated on: December 28,2023

Rucaparib efficacious in metastatic castration-resistant prostate cancer

by Elana GotkineFor patients with metastatic castration-resistant prostate cancer, treatment with rucaparib is associated with significantly longer duration of imaging-based progression-free survival

Updated on:December 28,2023